Delays in clinical trial enrollment and difficulties enrolling representative samples continue to vex sponsors, sites, and patient populations. Physician’s Weekly reports on an investigated use of an artificial intelligence-powered technology, Mendel.ai, as a means of...
Oncology Trials
Category
UK Oncology Trial Patient Feedback Not Being Included into the Record: Patient Engagement Now!
The University of Birmingham and Macmillan Cancer Support urge researchers to use newly developed guidelines so factoring in all material data into published materials so that patients can be fully informed about how cancer drugs affect quality of life. What...
Nektar Discusses REVEAL Trial Data in Ongoing Study
Biopharmaceutical sponsor Nektar recently announced in a press release early results from the ongoing dose-escalation stage of the first-in-human REVEAL Phase 1/2 clinical study evaluating the safety and efficacy of NKRT-262, a novel toll-like receptor (TLR) 7/8...
Changes in Cancer Trial Designs After Enrollment Initiation Common and Often Unreported
As published in JAMA Oncology, University of Toronto researchers have found that changes in the design of cancer drug trials after patient enrollment began appeared common and were left frequently unreported. The researchers reviewed 101 clinical trials between...